# Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection

> **NCT02141373** · NA · UNKNOWN · sponsor: **King Hussein Cancer Center** · enrollment: 136 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Glubran 2

## Key facts

- **NCT ID:** NCT02141373
- **Lead sponsor:** King Hussein Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2015-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141373, "Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02141373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*